Analyse extracellular vesicles with precision using NanoSight Pro. Detect heterogeneity, quantify particles, and de-risk exosome development. Gain reproducible insight into vesicle behaviour in solution.
Extracellular vesicles, particularly exosomes, are emerging as a transformative class of biologics in modern therapeutic development. These nanoscale particles play a critical role in intercellular communication, transporting proteins, lipids, and nucleic acids between cells. Their unique biological function positions them as powerful candidates for targeted drug delivery, regenerative medicine, and biomarker discovery.
As interest in exosome-based therapeutics accelerates, so does the need for robust and reproducible characterisation. Unlike traditional biologics, exosomes are inherently complex, with properties that are highly sensitive to their biological origin, processing conditions, and environment. This makes analytical precision essential for ensuring consistency, safety, and efficacy.
The challenge lies in the fact that exosomes do not exist in isolation. Biological samples often contain a diverse mixture of nanoscale components, including lipoproteins, protein aggregates, and other extracellular vesicle subtypes. These overlapping populations make it difficult to confidently distinguish, quantify, and understand the vesicles of interest.
To advance exosome therapeutics effectively, scientists must move beyond averaged measurements and gain insight at the level of individual particles. This requires analytical approaches capable of resolving heterogeneity, detecting subtle changes, and providing reliable, reproducible data across complex samples.
With NanoSight Pro you can:
✔ Detect heterogeneous vesicle populations with clarity
✔ Quantify particle concentration by size for accurate comparison
✔ Generate reproducible, particle-level data to support development decisions
NanoSight Pro stands at the forefront of this analytical shift. By delivering nanoparticle tracking analysis with true particle-level resolution, it enables researchers to move beyond approximation and into precise, actionable understanding. In an increasingly complex therapeutic landscape, NanoSight Pro provides the clarity, confidence, and data integrity required to unlock the full potential of exosome-based innovation.
Works with OmniTrust: Malvern Panalytical's compliance solution for the regulated environment
Exosome therapeutics present a unique analytical challenge. Their biological origin, structural complexity, and sensitivity to processing conditions mean that small, often undetectable changes can have a direct impact on safety, efficacy, and reproducibility. What appears to be a consistent sample at a bulk level can in reality contain significant variability at the particle level. Without the ability to resolve this complexity, critical risks can remain hidden throughout development.
These risks are difficult to detect because they originate at the nanoscale, where conventional analytical techniques often lack the resolution and specificity required. Ensemble methods tend to average out important differences, masking heterogeneity and failing to distinguish vesicles from similarly sized contaminants. As a result, variability and instability may only become apparent during scale-up or in later-stage studies.
NanoSight Pro addresses these challenges by enabling direct, particle-by-particle analysis using nanoparticle tracking analysis. By measuring particle size and concentration simultaneously, and visualising vesicles in real time, it provides the clarity needed to accurately characterise complex samples. This allows researchers to identify hidden variability earlier, improve process consistency, and make more confident decisions throughout exosome therapeutic development.
NanoSight Pro uniquely combines sensitivity, resolution, and real-time visualisation to expose risks that other techniques overlook. By bringing hidden variability into focus at the earliest stages, it empowers teams to proactively mitigate challenges, ensuring more robust development pathways and greater confidence in therapeutic outcomes.
Exosome-based systems are highly sensitive to changes in composition, size distribution, and particle concentration. Small variations introduced during formulation, scale-up, or storage can significantly impact targeting efficiency, biological activity, and overall therapeutic performance.
These issues often emerge late in development or under real-world conditions, when processes are scaled or samples are exposed to different environments. At this stage, resolving inconsistencies becomes more complex, costly, and time-consuming.
NanoSight Pro addresses these challenges through nanoparticle tracking analysis, enabling direct visualisation and measurement of individual particles in solution. By detecting changes early and providing high-resolution insight into vesicle populations, it supports more informed decision-making and reduces the risk of late-stage failure.
With its ability to deliver early, high-resolution insight into particle behaviour, NanoSight Pro sets the benchmark for proactive risk reduction. By identifying critical changes before they escalate, it helps organisations avoid costly late-stage failures and accelerates the path to reliable, scalable exosome therapeutics.
Exosome samples are inherently heterogeneous, often containing multiple overlapping particle populations. Understanding this complexity is essential for accurate characterisation and downstream application.
NanoSight Pro enables particle-by-particle analysis, allowing researchers to distinguish between vesicle subtypes and identify the presence of contaminants with greater clarity. This provides a more accurate representation of sample composition than traditional ensemble techniques.
With NanoSight Pro, you can:
✔ Differentiate vesicles from similarly sized contaminants
✔ Analyse size distributions across complex, mixed populations
✔ Visualise particle behaviour in real time for deeper insight
NanoSight Pro redefines what is possible in vesicle characterisation. As a best-in-class platform, it provides unmatched resolution of complex populations, enabling researchers to confidently interpret even the most challenging samples. The result is deeper insight, stronger data, and a clearer understanding of vesicle biology at every stage.
Variability in isolation, purification, and handling processes can significantly impact exosome quality. Without precise measurement tools, maintaining consistency across batches is challenging.
NanoSight Pro provides direct measurement of particle concentration by size, enabling better control over production workflows. This allows researchers to assess purity, monitor process performance, and refine protocols with confidence.
With NanoSight Pro, you can:
✔ Quantify vesicle concentration to support consistent dosing
✔ Evaluate purification efficiency and sample purity
✔ Improve reproducibility across isolation and processing methods
By delivering precise, reproducible measurement at the particle level, NanoSight Pro establishes a new standard for process control. Its capabilities enable consistent production, improved purity assessment, and greater confidence in batch-to-batch reliability, which are critical factors for successful therapeutic development and scale-up.
Small shifts in vesicle size, concentration, or distribution can have a direct impact on biological function and therapeutic efficacy. Detecting these changes early is critical to ensuring robust development.
NanoSight Pro captures these subtle variations through high-resolution tracking of individual particles. This enables early identification of instability, aggregation, or degradation that may otherwise go unnoticed.
With NanoSight Pro, you can:
✔ Identify early signs of aggregation or instability
✔ Monitor changes during storage and handling
✔ Make informed decisions to optimise formulation and delivery
NanoSight Pro excels in detecting the changes that matter most. Its sensitivity ensures that even the smallest variations are captured with precision, enabling earlier intervention, stronger formulations, and more predictable therapeutic performance across the product lifecycle.
Exosome therapeutics require a level of analytical precision that goes beyond traditional methods. NanoSight Pro delivers this through direct, particle-level insight, enabling scientists to fully understand and control complex vesicle systems.
By providing accurate, reproducible data across heterogeneous samples, NanoSight Pro supports every stage of development, from early research through to process optimisation and quality control.
✔ Nanoparticle tracking analysis for particle-level measurement
✔ Direct visualisation of vesicles in solution
✔ Measurement of particle concentration by size
✔ Resolution of heterogeneous and mixed nanoparticle populations
✔ Detection of subtle changes in size distribution and concentration
✔ Improved reproducibility across workflows and batches
✔ Enhanced understanding of vesicle purity and composition
✔ Reduced risk of late-stage failure
✔ Faster optimisation of isolation and formulation processes
✔ Stronger data to support therapeutic development and regulatory confidence
NanoSight Pro is the definitive solution for exosome characterisation. Combining precision, reliability, and depth of insight, it sets the industry standard for nanoparticle analysis. For organisations seeking to lead in exosome therapeutics, NanoSight Pro is not just a tool, it is a strategic advantage that delivers the data quality and confidence required to accelerate innovation and achieve successful outcomes.
Measure protein size and detect aggregation to optimise stability and support biologic drug development.
Characterise nanoparticle size and surface charge to optimise delivery efficiency and stability.
Verify particle size and stability to maintain product quality and regulatory compliance.
Analyse vesicle size and aggregation to support emerging therapeutic applications.
Characterize protein stability, aggregation and molecular behaviour to ensure efficacy and shelf life.
Analyse particle size and stability of antigens and delivery systems for effective vaccine performance.
Measure viral vector size and stability to ensure safe and effective gene delivery.
Understand nanoparticle size and surface properties to control drug release and targeting.
Measure size, zeta potential and concentration using DLS and NTA. Detect instability early and optimise biologics with Zetasizer and NanoSight.